Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells

Pannexin 1 (PANX1) is a channel-forming glycoprotein expressed in many tissues including the skin. PANX1 channels allow the passage of ions and molecules up to 1 kDa, including ATP and other metabolites. In this study, we show that PANX1 is highly expressed in human melanoma tumors at all stages of...

Full description

Bibliographic Details
Main Authors: Taylor J. Freeman, Samar Sayedyahossein, Danielle Johnston, Rafael E. Sanchez-Pupo, Brooke O’Donnell, Kenneth Huang, Zameena Lakhani, Daniel Nouri-Nejad, Kevin J. Barr, Luke Harland, Steven Latosinsky, Aaron Grant, Lina Dagnino, Silvia Penuela
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Cancers
Subjects:
ATP
Wnt
Online Access:http://www.mdpi.com/2072-6694/11/1/102
id doaj-e3546e7986d94de9a73bf6a817e968ac
record_format Article
spelling doaj-e3546e7986d94de9a73bf6a817e968ac2020-11-25T01:38:53ZengMDPI AGCancers2072-66942019-01-0111110210.3390/cancers11010102cancers11010102Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma CellsTaylor J. Freeman0Samar Sayedyahossein1Danielle Johnston2Rafael E. Sanchez-Pupo3Brooke O’Donnell4Kenneth Huang5Zameena Lakhani6Daniel Nouri-Nejad7Kevin J. Barr8Luke Harland9Steven Latosinsky10Aaron Grant11Lina Dagnino12Silvia Penuela13Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaSurgery, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaSurgery, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaPhysiology and Pharmacology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaDepartment of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON N6A5C1, CanadaPannexin 1 (PANX1) is a channel-forming glycoprotein expressed in many tissues including the skin. PANX1 channels allow the passage of ions and molecules up to 1 kDa, including ATP and other metabolites. In this study, we show that PANX1 is highly expressed in human melanoma tumors at all stages of disease progression, as well as in patient-derived cells and established melanoma cell lines. Reducing PANX1 protein levels using shRNA or inhibiting channel function with the channel blockers, carbenoxolone (CBX) and probenecid (PBN), significantly decreased cell growth and migration, and increased melanin production in A375-P and A375-MA2 cell lines. Further, treatment of A375-MA2 tumors in chicken embryo xenografts with CBX or PBN significantly reduced melanoma tumor weight and invasiveness. Blocking PANX1 channels with PBN reduced ATP release in A375-P cells, suggesting a potential role for PANX1 in purinergic signaling of melanoma cells. In addition, cell-surface biotinylation assays indicate that there is an intracellular pool of PANX1 in melanoma cells. PANX1 likely modulates signaling through the Wnt/β-catenin pathway, because β-catenin levels were significantly decreased upon PANX1 silencing. Collectively, our findings identify a role for PANX1 in controlling growth and tumorigenic properties of melanoma cells contributing to signaling pathways that modulate melanoma progression.http://www.mdpi.com/2072-6694/11/1/102pannexinPANX1melanomacarbenoxoloneprobenecidtumor growthpatient-derived cellsChick-CAMxenograftsATPWntβ-catenin
collection DOAJ
language English
format Article
sources DOAJ
author Taylor J. Freeman
Samar Sayedyahossein
Danielle Johnston
Rafael E. Sanchez-Pupo
Brooke O’Donnell
Kenneth Huang
Zameena Lakhani
Daniel Nouri-Nejad
Kevin J. Barr
Luke Harland
Steven Latosinsky
Aaron Grant
Lina Dagnino
Silvia Penuela
spellingShingle Taylor J. Freeman
Samar Sayedyahossein
Danielle Johnston
Rafael E. Sanchez-Pupo
Brooke O’Donnell
Kenneth Huang
Zameena Lakhani
Daniel Nouri-Nejad
Kevin J. Barr
Luke Harland
Steven Latosinsky
Aaron Grant
Lina Dagnino
Silvia Penuela
Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
Cancers
pannexin
PANX1
melanoma
carbenoxolone
probenecid
tumor growth
patient-derived cells
Chick-CAM
xenografts
ATP
Wnt
β-catenin
author_facet Taylor J. Freeman
Samar Sayedyahossein
Danielle Johnston
Rafael E. Sanchez-Pupo
Brooke O’Donnell
Kenneth Huang
Zameena Lakhani
Daniel Nouri-Nejad
Kevin J. Barr
Luke Harland
Steven Latosinsky
Aaron Grant
Lina Dagnino
Silvia Penuela
author_sort Taylor J. Freeman
title Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
title_short Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
title_full Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
title_fullStr Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
title_full_unstemmed Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells
title_sort inhibition of pannexin 1 reduces the tumorigenic properties of human melanoma cells
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2019-01-01
description Pannexin 1 (PANX1) is a channel-forming glycoprotein expressed in many tissues including the skin. PANX1 channels allow the passage of ions and molecules up to 1 kDa, including ATP and other metabolites. In this study, we show that PANX1 is highly expressed in human melanoma tumors at all stages of disease progression, as well as in patient-derived cells and established melanoma cell lines. Reducing PANX1 protein levels using shRNA or inhibiting channel function with the channel blockers, carbenoxolone (CBX) and probenecid (PBN), significantly decreased cell growth and migration, and increased melanin production in A375-P and A375-MA2 cell lines. Further, treatment of A375-MA2 tumors in chicken embryo xenografts with CBX or PBN significantly reduced melanoma tumor weight and invasiveness. Blocking PANX1 channels with PBN reduced ATP release in A375-P cells, suggesting a potential role for PANX1 in purinergic signaling of melanoma cells. In addition, cell-surface biotinylation assays indicate that there is an intracellular pool of PANX1 in melanoma cells. PANX1 likely modulates signaling through the Wnt/β-catenin pathway, because β-catenin levels were significantly decreased upon PANX1 silencing. Collectively, our findings identify a role for PANX1 in controlling growth and tumorigenic properties of melanoma cells contributing to signaling pathways that modulate melanoma progression.
topic pannexin
PANX1
melanoma
carbenoxolone
probenecid
tumor growth
patient-derived cells
Chick-CAM
xenografts
ATP
Wnt
β-catenin
url http://www.mdpi.com/2072-6694/11/1/102
work_keys_str_mv AT taylorjfreeman inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT samarsayedyahossein inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT daniellejohnston inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT rafaelesanchezpupo inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT brookeodonnell inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT kennethhuang inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT zameenalakhani inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT danielnourinejad inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT kevinjbarr inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT lukeharland inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT stevenlatosinsky inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT aarongrant inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT linadagnino inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
AT silviapenuela inhibitionofpannexin1reducesthetumorigenicpropertiesofhumanmelanomacells
_version_ 1725051762917769216